Agilent Technologies, Inc. (A)
$
138.23
+1.61 (1.16%)
Key metrics
Financial statements
Free cash flow per share
4.9193
Market cap
39.2 Billion
Price to sales ratio
5.7737
Debt to equity
0.5352
Current ratio
2.2479
Income quality
1.2254
Average inventory
1 Billion
ROE
0.1997
Technology
Technology – consumer electronics
Largecap
With a market cap of 121,78 bil stock is ranked 1
Low risk
ISS score of this stock is ranked 1
Company description
Profile
Agilent Technologies, Inc. provides application-focused solutions to life sciences, diagnostics, and applied chemical markets globally. The Life Sciences and Applied Markets segment delivers a wide array of analytical instruments and systems, including liquid chromatography systems and components, mass spectrometry systems, gas chromatography systems, and various spectroscopy technologies. The company's innovative approach is evident in its diverse offerings such as cell analysis plate-based assays, flow cytometers, laboratory automation tools, and dissolution testing equipment. Additionally, Agilent incurred an interest expense of $96,000,000.00 reflecting its debt servicing obligations. The gross profit ratio is 0.54 which highlights the efficiency of the company's production and sales operations. Furthermore, the diluted EPS is $4.43 accounting for potential share dilution, while the net income ratio stands at 0.20 demonstrating the company's profitability margin. The reported depreciation and amortization expenses amount to $257,000,000.00 underscoring the wear and tear of its assets. On the diagnostics front, Agilent offers advanced technologies for DNA analysis, including arrays for mutation detection and next-generation sequencing, along with reagents for turbidimetry. In addition, Agilent CrossLab segment delivers essential laboratory supplies and services such as custom chemistries and sample preparation products. The stock is reasonably priced at $126.32 appealing to a broad range of investors. With a high average trading volume of 1,715,825.00 there is strong liquidity in the stock, making it an attractive option for market participants. The company showcases a mid-range market capitalization of $39,191,551,272.00 positioning it as a steady performer within the sector. As a key player in the Medical - Diagnostics & Research industry, Agilent significantly contributes to the overall market landscape, driving innovation and growth within the Healthcare sector. Its comprehensive range of products is marketed through direct sales, distributors, and electronic commerce, ensuring a broad reach in delivering its advanced solutions to a global clientele.
Investing in Agilent Technologies, Inc. (A) depends on multiple factors, including revenue growth, profit margins, debt-to-equity ratio, earnings per share, and return on equity. Analysts have rated it as B+, with a Bullish outlook. Always conduct your own research before investing.
Analysts predict Agilent Technologies, Inc. stock to fluctuate between $96.43 (low) and $153.84 (high) in the next 365 days, reflecting market expectations and potential volatility.
As of 2025-10-13, Agilent Technologies, Inc.'s market cap is $39,191,551,272, based on 283,524,208 outstanding shares.
Compared to Eli Lilly & Co., Agilent Technologies, Inc. has a Lower Market-Cap, indicating a difference in performance.
Agilent Technologies, Inc. pays dividends. The current dividend yield is 0.77%, with a payout of $0.25 per share.
To buy Agilent Technologies, Inc. (A) stock: Open a brokerage account (e.g., Robinhood, TD Ameritrade, E-Trade). Search for A. Place an order (Market, Limit, etc.).
The best time to invest depends on market trends and technical indicators, which show a Bullish trend based on economic conditions and company performance.
Agilent Technologies, Inc.'s last stock split was 699:500 on 2014-11-03.
Revenue: $6,510,000,000 | EPS: $4.44 | Growth: 5.21%.
Visit https://www.agilent.com/investor-relations for detailed financial reports.
You can explore historical data from here
All-time high: $179.57 (2021-09-03) | All-time low: $96.43 (2025-04-09).
Key trends include market demand, economic conditions, interest rates, and industry competition, which influence the stock's performance.
News
prnewswire.com
BEIJING , Oct. 9, 2025 /PRNewswire/ -- Elong Power Holding Limited. (NASDAQ: ELPW) (the "Company"), today announced that it received a notification letter, dated October 3, 2025 (the "Notification Letter "), from the Listing Qualifications Department of The Nasdaq Stock Market Inc. (the "Nasdaq"), notifying the Company that it is not in compliance with the requirement to maintain a minimum closing bid price of $1.00 per share, as set forth in Nasdaq Listing Rule 5450(a)(1), because the closing bid price of the Company's ordinary shares was below $1.00 per share for 30 consecutive business days.
proactiveinvestors.com
Citi analysts had a “constructive” meeting with Agilent Technologies Inc (NYSE:A) management this week, given the various growth drivers for the company into next year. This “should translate into earnings leverage," the analysts wrote in a note to clients on Thursday.
businesswire.com
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced that President and CEO Padraig McDonnell will participate in a fireside chat at this year's Bank of America Global Healthcare Conference in London. The fireside chat will be at 9:50-10:30 a.m. British Summer Time (BST) on Sept. 25 in London. A live audio webcast and replay of the presentation will be available on the Agilent Investor Relations website. About Agilent Technologies Agilent Technologies Inc. (.
youtube.com
Padraig McDonnell, CEO of Agilent (A), joins to discuss the company's latest earnings. Agilent creates analytical instruments and software for life science markets: “we enable breakthroughs” in areas like cancer research and more.
seekingalpha.com
Agilent Technologies, Inc. (NYSE:A ) Wells Fargo 20th Annual Healthcare Conference 2025 September 3, 2025 11:00 AM EDT Company Participants Padraig McDonnell - CEO, President & Director Rodney Gonsalves - Interim CFO, Principal Accounting Officer, VP & Corporate Controller Conference Call Participants Brandon Couillard - Wells Fargo Securities, LLC, Research Division Presentation Brandon Couillard MD & Equity Analyst All right. Good morning.
zacks.com
Evaluate Agilent's (A) reliance on international revenue to better understand the company's financial stability, growth prospects and potential stock price performance.
zacks.com
A posts fiscal Q3 earnings and revenue beats, with double-digit sales growth and upbeat guidance lifting shares.
seekingalpha.com
Agilent Technologies, Inc. (NYSE:A ) Q3 2025 Earnings Conference Call August 27, 2025 4:30 PM ET Company Participants Angelica A. Riemann - Senior VP & President of Agilent CrossLab Group Jian Miao Zhang - Senior VP & President of Applied Markets Group Padraig McDonnell - CEO, President & Director Parmeet Ahuja - Vice President of Investor Relations Rodney Gonsalves - Interim CFO, Principal Accounting Officer, VP & Corporate Controller Simon May - SVP & President of LDG Conference Call Participants Daniel Gregory Brennan - TD Cowen, Research Division Daniel Louis Leonard - UBS Investment Bank, Research Division Douglas Anthony Schenkel - Wolfe Research, LLC Jack Meehan - Nephron Research LLC Michael Leonidovich Ryskin - BofA Securities, Research Division Patrick Bernard Donnelly - Citigroup Inc., Research Division Puneet Souda - Leerink Partners LLC, Research Division Rachel Marie Vatnsdal Olson - JPMorgan Chase & Co, Research Division Tycho W.
zacks.com
Although the revenue and EPS for Agilent (A) give a sense of how its business performed in the quarter ended July 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
zacks.com
Agilent Technologies (A) came out with quarterly earnings of $1.37 per share, beating the Zacks Consensus Estimate of $1.36 per share. This compares to earnings of $1.32 per share a year ago.
See all news